Skip to content

Dr. Aimen Arij

What Is Pentadeca Arginate (PDA)? Structure, Evidence Status and How It Compares to BPC-157

Pentadeca Arginate (PDA) is not a new peptide. It is the same 15–amino–acid sequence as BPC-157 — GEPPPGKPADDAGLV — supplied as an…

What Is L-Carnitine? The Carnitine Shuttle and What the Research Actually Shows

L-carnitine is not a peptide. It is a small quaternary ammonium compound (a betaine) that the body builds from the amino acids…

IGF-1 DES vs IGF-1 LR3: Half-Life, Potency and Why They Are Not Interchangeable

DES(1-3)IGF-1 and IGF-1 LR3 are both engineered analogs of human IGF-1 built to do the same job — escape capture by the…

How to Travel With Peptides: Storage, Cold Chain and Border Rules

The short answer: travel with sealed, unreconstituted powder in its original labelled vial, in your carry-on, and treat freezing — not warmth…

GLP-1 Microdosing: What the Evidence Actually Shows

Short answer: no published controlled trial has tested GLP-1 microdosing as a long-term regimen, so nobody can tell you it works —…

Where to Inject GHK-Cu: Routes Used in Research and Why the Evidence Is Topical

Short answer: there is no injection site for GHK-Cu, because there is no human injection evidence for GHK-Cu. Essentially every human dataset…

Where to Inject Sermorelin: What the Approved Label and Studies Actually Used

The short answer: sermorelin was given subcutaneously — once daily, at bedtime — when it was an approved US drug, and the…

How Long Is Bacteriostatic Water Good For? Shelf Life and the 28-Day Rule

Bacteriostatic Water for Injection, USP carries two separate clocks, and they answer two different questions. The printed expiration date on a sealed…

Does Tirzepatide Cause Constipation? What the Trial Data and Labels Report

Yes — constipation is a labelled adverse reaction of tirzepatide, and it appears in the FDA-approved prescribing information for both branded products.…

What Is Eloralintide? The Selective Amylin Agonist and What Its Phase 2 Data Show

Eloralintide (development code LY3841136) is Eli Lilly’s investigational once-weekly selective amylin receptor agonist — a synthetic amylin analogue engineered to activate the…